Overview
- TickerWNDW on OTC2
- IndustryIndustrial Organic Chemicals2
- HeadquartersColumbia, United States2
- Incorporated inNV4
- Business address9375 E. Shea Blvd, Suite 107-B, Scottsdale, Az 852604
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formProfit Corporation2
- LEI549300XM5GQRUCS318292
- StatusActive2
- LEI statusIssued and current2
- Registered addressc/o CORPORATE CREATIONS NETWORK INC., 112 NORTH CURRY STREET, 89703 Carson City, United States2
- Registered withBusiness Center (Secretary of State), NV199812182472
See how the biggest companies compare on our leaderboards
National Renewable Energy Laboratory (“ NREL ”), through a Cooperative Research and Development Agreement (“ CRADA ”).5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-08-31 | 2024-08-31 |
|---|---|---|
| Selling, general and administrative | $1.7M | $2.0M |
| Research and development | $621.9K | $594.0K |
| Total operating expenses | $2.4M | $2.6M |
| Loss from operations | -$2.4M | -$2.6M |
| Interest income | $144.4K | $242.4K |
| Impairment of fixed assets | -$684.0K | |
| Total other income (expense) | $144.4K | -$441.6K |
| Net loss from continuing operations | -$2.2M | -$3.0M |
| Net loss from discontinued operations | -$45.9K | -$7.9K |
| Deemed dividend attributable to warrant modification | -$400.0K | |
| Net loss attributable to common stockholders | -$2.3M | -$3.5M |
| Foreign currency translation gain | $0 | $1.5K |
| Comprehensive loss | -$2.3M | -$3.5M |
| Loss per Share from continuing operations basic | -$0 | -$0 |
| Loss per Share from continuing operations diluted | -$0 | -$0 |
| Loss per Share from discontinued operations basic | $0 | $0 |
| Loss per Share from discontinued operations diluted | $0 | $0 |
| Loss per Share basic | -$0.04 | -$0.06 |
| Loss per Share diluted | -$0.04 | -$0.06 |
| Weighted average number of common shares outstanding - basic | 55.8M shares | 53.2M shares |
| Weighted average number of common shares outstanding - diluted | 55.8M shares | 53.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.3
| Period ending | 2025-08-31 | 2024-08-31 | 2023-08-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.6M | $1.2M | |
| Short-term investments | $3.0M | ||
| Deferred research and development costs | $30.7K | $45.7K | |
| Prepaid expenses and other current assets | $15.8K | $681.5K | |
| Current assets of discontinued operations | $13.5K | ||
| Total current assets | $6.6M | $5.0M | |
| Property and Equipment, net of accumulated depreciation of $144,302 and $136,246, respectively | $43.1K | $13.5K | |
| Total assets | $6.6M | $5.0M | |
| Accounts payable and accrued expenses | $114.3K | $85.9K | |
| Related party payables | $79.9K | $113.1K | |
| Current liabilities of discontinued operations | $122.5K | ||
| Total current liabilities | $194.2K | $321.5K | |
| Total liabilities | $194.2K | $321.5K | |
| Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 and 53,198,399 shares issued and outstanding at August 31, 2025 and 2024, respectively | $65.8K | $53.2K | |
| Additional paid-in capital | $87.5M | $83.5M | |
| Accumulated other comprehensive (loss) | -$76.7K | ||
| Retained deficit | -$81.1M | -$78.8M | |
| Total stockholders' equity | $6.5M | $4.7M | $7.3M |
| Total liabilities and stockholders' equity | $6.6M | $5.0M | |
| Property and Equipment accumulated depreciation | $144.3K | $136.2K | |
| Preferred stock, par value | $0.10 | $0.10 | |
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |
| Common stock, shares issued | 65.8M shares | 53.2M shares | |
| Common stock, shares outstanding | 65.8M shares | 53.2M shares |
| Period ending | 2025-08-31 | 2024-08-31 | 2023-08-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.6M | $1.2M | |
| Short-term investments | $3.0M | ||
| Deferred research and development costs | $30.7K | $45.7K | |
| Prepaid expenses and other current assets | $15.8K | $681.5K | |
| Current assets of discontinued operations | $13.5K | ||
| Total current assets | $6.6M | $5.0M | |
| Property and Equipment, net of accumulated depreciation of $144,302 and $136,246, respectively | $43.1K | $13.5K | |
| Total assets | $6.6M | $5.0M | |
| Accounts payable and accrued expenses | $114.3K | $85.9K | |
| Related party payables | $79.9K | $113.1K | |
| Current liabilities of discontinued operations | $122.5K | ||
| Total current liabilities | $194.2K | $321.5K | |
| Total liabilities | $194.2K | $321.5K | |
| Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 and 53,198,399 shares issued and outstanding at August 31, 2025 and 2024, respectively | $65.8K | $53.2K | |
| Additional paid-in capital | $87.5M | $83.5M | |
| Accumulated other comprehensive (loss) | -$76.7K | ||
| Retained deficit | -$81.1M | -$78.8M | |
| Total stockholders' equity | $6.5M | $4.7M | $7.3M |
| Total liabilities and stockholders' equity | $6.6M | $5.0M | |
| Property and Equipment accumulated depreciation | $144.3K | $136.2K | |
| Preferred stock, par value | $0.10 | $0.10 | |
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |
| Common stock, shares issued | 65.8M shares | 53.2M shares | |
| Common stock, shares outstanding | 65.8M shares | 53.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-08-31 | 2024-08-31 |
|---|---|---|
| Loss from continuing operations | -$2.3M | -$3.1M |
| Depreciation | $8.1K | $11.1K |
| Stock based compensation expense | $103.1K | $403.5K |
| Impairment of assets | $684.0K | |
| Loss on discontinued operations | $76.7K | |
| Deferred research and development costs | $15.0K | $11.0K |
| Prepaid expenses and other assets | $678.2K | $168.8K |
| Accounts payable and accrued expenses | -$93.1K | -$40.2K |
| Related party payable | -$33.3K | $76.1K |
| Net cash used in operating activities | -$1.5M | -$1.7M |
| Purchase of short-term investments | -$4.0M | |
| Redemption of short-term investments | $3.0M | $6.5M |
| Capital expenditures | -$37.7K | -$1.9K |
| Net cash provided by investing activities | $3.0M | $2.5M |
| Proceeds from the issuance of equity securities, net | $3.8M | |
| Net cash from financing activities | $3.8M | |
| Effect of exchange rate changes on cash and cash equivalents | -$1 | |
| Net increase in cash and cash equivalents | $5.3M | $756.8K |
No quarter-by-quarter statement was filed.
What it owns
What SolarWindow Technologies, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $187.4K3 Aug 31, 2025 | $149.7K3 Aug 31, 2024 | +25.2% |
| Accumulated depreciation | $144.3K3 Aug 31, 2025 | $136.2K3 Aug 31, 2024 | +5.9% |
| Property and equipment, net | $43.1K3 Aug 31, 2025 | $13.5K3 Aug 31, 2024 | +220.2% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $6.6M3 Aug 31, 2025 | $1.2M3 Aug 31, 2024 | +424.7% |
| Marketable securities, current | $3.0M3 Aug 31, 2024 | $5.5M6 Aug 31, 2023 | −45.5% |
Properties, in its own words
Our corporate office is located at 9375 E. Shea Blvd., Suite 107-B, Scottsdale, AZ 85260. The office is provided free from rent by a shareholder.
Item 2 of the 10-K filed Nov 13, 2025.5
Leadership
Who has led SolarWindow Technologies, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerNicholas S. Cucinelli Sep 20, 2007 to Mar 6, 200814
- PresidentNicholas S. Cucinelli Sep 20, 2007 to Mar 6, 200814
- Chief financial officerFrank J. Fabio Jan 14, 2009 to Jan 14, 200915
Board members and other officers (7)
- SECRETARY, TREASURERHarmel S. Rayat Sep 9, 2008 to Sep 9, 200816
- Board memberJatinder S. Bhogal Jan 14, 2009 to Jan 14, 200917
- Board memberJoseph Sierchio Jul 31, 2008 to Jan 14, 200918
- Board memberHarmel S. Rayat Sep 9, 2008 to Sep 9, 200816
- Board memberNicholas S. Cucinelli Sep 20, 2007 to Mar 6, 200814
- Board memberThomas N. Gladwin Sep 20, 2007 to Mar 11, 200819
- Board memberAlastair K. Livesey Nov 9, 2007 to Mar 11, 200820
Former names
Timeline
- Dec 12, 20258-K Regulation FD disclosure21
- Nov 26, 20258-K Executive or director change; Regulation FD disclosure22
- Aug 7, 20258-K Executive or director change23
- Jun 20, 20258-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure24
- May 12, 20258-K Other events25
- May 21, 20248-K Executive or director change26
- Apr 12, 20248-K Executive or director change27
- Mar 5, 20248-K Executive or director change; Other events28
- Mar 7, 20238-K Other events29
- Jan 19, 20238-K Completed an acquisition or sale; Executive or director change; Other events30
- Dec 22, 20228-K Change in control; Executive or director change31
- Dec 15, 20228-K Other events32
- Sep 20, 2007New chief executive Nicholas S. Cucinelli becomes CEO14
- May 5, 1998Founded SolarWindow Technologies, Inc. is founded2
Filings
64 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 20 major events, 22 other. The latest 20:
- Jul 13, 202610-Q EDGAR
- May 20, 2026EFFECT EDGAR
- May 18, 2026CORRESP EDGAR
- Apr 29, 2026S-1/A EDGAR
- Apr 9, 202610-Q EDGAR
- Mar 20, 2026POS AM EDGAR
- Mar 20, 2026S-1/A EDGAR
- Jan 9, 202610-Q EDGAR
- Dec 12, 20258-K EDGAR
- Nov 26, 20258-K EDGAR
- Nov 13, 202510-K EDGAR
- Oct 9, 2025S-1 EDGAR
- Aug 7, 20258-K EDGAR
- Jul 11, 202510-Q EDGAR
- Jun 20, 20258-K EDGAR
- May 12, 20258-K EDGAR
- Apr 11, 202510-Q EDGAR
- Apr 9, 2025EFFECT EDGAR
- Apr 4, 2025POS AM EDGAR
- Mar 27, 2025POS AM EDGAR
The 64 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Winch Advisory Services, LLC | 216 | $59 | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How SolarWindow Technologies, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSolarWindow Technologies, Inc.1
- CIK0001071840
- Employer ID (EIN)59-35096945
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inNevada5
- Fiscal year endsAugust 311
- Industry code (SIC)2860 Industrial Organic Chemicals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address9375 E. Shea Blvd, Suite 107-B, Scottsdale, AZ 852601
- Phone800-213-06891
- Shares outstanding65,779,045 as of Jul 10, 202613
- Public float$5.5M as of Feb 28, 20255
- AuditorPKF O’Connor Davies, LLP, New York PCAOB ID 1275
- On EDGAR sinceAug 30, 20051
- Filings561 in all: 8-K (258), 10-Q (55), CORRESP (35), EFFECT (30), POS AM (26), UPLOAD (24), 10-K (18), S-1/A (14)1
All 34 form types
CT ORDER (11), S-8 POS (10), 8-K/A (9), S-1 (9), 10QSB (7), 424B3 (7), 3 (6), NT 10-K (6), 4 (5), SB-2/A (5), 10-K/A (3), NT 10-Q (3), SC 13D/A (3), 10-Q/A (2), 10KSB (2), 424B7 (2), SB-2 (2), 4/A (1), 424B4 (1), D (1), DEF 14C (1), PRE 14C (1), REGDEX (1), S-3 (1), S-8 (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Nov 13, 2025
Quarterly report (10-Q) Jul 13, 2026
Latest 8-K (8-K) Dec 12, 2025
Risk factors and legal proceedings
The risks SolarWindow Technologies, Inc. names in Item 1A of its 10-K filed Nov 13, 2025: 70 risks under these headings, as written.5
- Risks Related to Our Financial Condition
- We have not generated any revenues and have experienced significant losses to date, and we expect to continue to incur losses for the foreseeable future.
- Our ability to use our net operating loss to offset future taxable income may be subject to certain limitations.
- We will require additional financing in the future to maintain and expand operations into advanced stages of product development and fabrication, and failure to obtain such financing would have a material adverse effect on our business, operating results, financial condition and prospects.
- Raising additional capital may cause dilution to our existing stockholders and may restrict our operations or require us to relinquish certain intellectual property rights.
- Because we cannot currently estimate the amount of funds or time required to commercialize our technologies, even if financing is available to us, we may secure less funding than is actually required to effectuate our business plan.
- Adverse conditions in the alternative energy industry or the global economy generally could have adverse effects on our results of operations and consequently the price of our Common Stock.
- An increase in raw material prices could have negative consequences for our long-term profitability.
- Risks Related to Our Technology, Operations and Commercialization Efforts
- The development of our technology is subject to the risks of failure inherent in the development of any novel technology.
- The success of our research and development activities is uncertain. If such efforts are not successful, we will be unable to generate revenues from our operations, and we may have to cease doing business.
- If we ultimately do not obtain the necessary regulatory and safe operation approvals for the commercialization of our technology, we will not achieve profitable operations, and your investment may be lost.
The other 60 risks
- We are operating in a highly fragmented and competitive market, and our competitors have several competitive advantages over us.
- Any products developed from or based on our technology will face competition from other companies producing solar power and/or energy harvesting or storage products.
- Technological changes could render our products uncompetitive or obsolete, which could prevent us from achieving market share and sales.
- To the extent we can develop and commercialize products, if such products do not gain market acceptance, we may not achieve sales and market share.
- If organic solar photovoltaic light energy harvesting technologies are not suitable for widespread adoption or sufficient demand for such products does not develop or takes longer to develop than we anticipate, we may not be able to profitably exploit our technology.
- Our growth and success depend on our ability to develop new products and services and adapt to market and customer needs.
- Our business model and strategy are based on growth through licensing, joint ventures, collaborative research and development agreements and acquisitions, that may be difficult to execute, and it may disrupt our business, create integration issues, impair our results of operations, dilute our stockholders’ ownership, cause us to incur debt, divert management resources, or cause us to incur significant expense.
- We may pursue strategic acquisitions, investments, strategic partnerships or other ventures, and our business could be materially harmed if we fail to successfully identify, complete and integrate such transactions.
- We may be the subject of product liability claims and other adverse effects due to defective products, design faults or harm caused to persons and property.
- We lack sales, marketing and manufacturing experience and will likely rely on third party marketers.
- We may not be able to integrate our process and/or technologies into a manufacturing process necessary to produce a manufacturable product.
- We could be exposed to liability if we experience security breaches or other disruptions, which could harm our reputation and business.
- Litigation and other legal proceedings may adversely affect our business, financial condition, and results of operations.
- We may be held liable for, or incur costs to settle, liability and remediation claims if any products we develop, or any products that use or incorporate any of our technologies, cause injury or are found unsuitable during product testing, manufacturing, marketing, sale or use. These risks exist even with respect to products that have received, or may in the future receive, regulatory approval, registration or clearance for commercial use. We cannot guarantee that we will be able to avoid product liability exposure.
- Mergers of, or other strategic transactions by, our competitors could weaken our competitive position or reduce our revenue.
- As noted above, on a going forward basis, we plan to make acquisitions, which could require significant management attention, disrupt our business, result in dilution to our stockholders, and adversely affect our financial results.
- Our insurance coverage may not be adequate to protect us from all business risks.
- Risks Related to Compliance with Laws and Regulations
- Our business is and may become subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data use and data protection, content, competition, safety and consumer protection, e-commerce, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our products and business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.
- There may be limitations on the effectiveness of our internal controls, and the failure of our control systems to prevent error or fraud may materially harm our Company.
- Our products or the application thereof will be subject to environmental, occupational safety & health regulations, as well as regulations dealing with, among other matters, harmful or hazardous materials.
- We are subject additional compliance expense as well potential liability for any alleged violations of the securities laws and regulations to which we are or may become subject to the “Securities Laws & Regulations”).
- Risks Related to Possible Expansion into Foreign Jurisdictions
- We may expand our operations abroad where we have limited operating experience and may be subject to increased business and economic risks that could affect our financial results.
- Risks Related to our Intellectual Property
- Our ability to operate profitably is directly related to our ability to develop, protect, and perfect rights in and to our proprietary technology.
- Our proprietary rights may not adequately protect our technologies and products.
- Confidentiality agreements with employees and others may not adequately prevent disclosure of trade secrets and other proprietary information.
- We may not be able to adequately protect our intellectual property right from infringement by unauthorized persons or competitors.
- We may not be able to protect our intellectual property rights throughout the world.
- If we fail to protect our intellectual property rights, our competitors may take advantage of our ideas and compete directly against us.
- Our intellectual property rights may not be sufficient to protect our competitive position and to prevent others from manufacturing, using or selling competing products.
- We may be accused of infringing the intellectual property rights of others.
- We may need to curtail or cease operations if, in the future, we are unable to obtain additional licenses pursuant to our collaborative development agreements required to maintain our rights to market products, if any, developed by us.
- Our failure to secure trademark registrations could adversely affect our business and our ability to market our products.
- We may be unable to adequately prevent disclosure of trade secrets and other proprietary information, or the misappropriation of the intellectual property we regard as our own.
- Our pending or future patent applications may not result in issued patents, and we cannot predict how long it may take for a patent to issue on any of our pending patent applications, assuming a patent is issued.
- Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property rights.
- The patent prosecution process is expensive and time-consuming, is highly uncertain and involves complex legal and factual questions. Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents.
- Risks Related to Our Personnel and Management
- Our success is very much dependent upon hiring and retaining highly qualified management and technical personnel.
- Due to the fact each of our three directors conducts outside business activities and are not our employees, attention and efforts will not be focused solely on our business activities, which may hinder our achieving our business objectives.
- Due to our small size each of our officers and consultants has a significant influence on our operations and access to sensitive information, which, if an officer or consultant goes rogue, could result in significant damage to, without limitation, the Company’s operations, reputation, financial health, and security of our intellectual property.
- Our articles of incorporation provide for indemnification of officers and directors at our expense and limit their liability, which may result in a major cost to us and hurt the interests of our stockholders because corporate resources may be expended for the benefit of officers and/or directors and may inhibit actions against our officers and directors.
- Risks Related To Ownership of Our Common Stock
- We are not a fully reporting company under the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act; therefore, we are subject only to the reporting requirements of Section 15(d) of the Exchange Act.
- Our Common Stock is currently quoted on the OTCID (Current Information) which may make it more difficult for you to purchase or sell shares of the Company’s Common Stock.
- Our Common Stock is not currently registered for trading on any national stock exchange and thus, should the price of our stock on the OTCID fall below five dollars per share and our net tangible assets fall below two million dollars our stock may be deemed a “penny stock,” in which case, you may find it difficult to, deposit, transfer, sell or purchase the shares of our Common Stock in open market transactions.
- Financial Industry Regulatory Authority (“FINRA”) sales practice requirements may also limit a stockholder’s ability to buy and sell our Common Stock, which could depress the price of our Common Stock.
- There is a limited market for our Common Stock, which may make it difficult for holders of our Common Stock to sell their stock.
- The trading price of our Common Stock has been and will likely continue to be volatile.
- If securities or industry analysts do not publish, or cease publishing, research or publish inaccurate or unfavorable research about our business or our market, or if they change their recommendations regarding our stock adversely, our stock price and any trading volume could decline.
- The sale or availability for sale of substantial amounts of our Common Stock could adversely affect their market price.
- Adverse publicity about us and/or our brands, including without limitation, through social media or in connection with brand damaging events and/or public perception, could adversely impact our business operations and results.
- As a smaller reporting company within the meaning of the Securities Act, we may utilize certain modified disclosure requirements, and we cannot be certain if these reduced requirements will make our Common Stock less attractive to investors.
- The sale by our stockholders of restricted shares, either pursuant to a resale prospectus or Rule 144, may adversely affect our ability to raise the funds we will require to effectuate our business plan.
- Kalen Capital Corporation (“KCC”), a private corporation solely owned by Mr. Harmel S. Rayat, beneficially owns approximately 61.58% of our issued and outstanding stock when giving effect to derivative securities owned by KCC. This ownership interest may preclude you from influencing significant corporate decisions.
- We are a “controlled company” and as a result our stockholders do not have the same protections afforded to stockholders of companies that are not “controlled companies”.
- The company may be subject to compliance with rules requiring the adoption of certain corporate governance measures, which require control measures for related party transactions, conflicts of interest and similar matters.
- There are options to purchase shares of our Common Stock currently outstanding.
- There are warrants to purchase shares of our Common Stock currently outstanding.
- We may issue preferred stock which may have greater rights than our Common Stock.
- The Company may sell additional equity securities in the future and your ownership interest in the Company may be diluted because of such sales.
- Our compliance with changing laws and rules regarding corporate governance and public disclosure may result in additional expenses to us which, in turn, may adversely affect our ability to continue our operations.
- Because we do not intend to pay dividends for the foreseeable future, you should not purchase our shares if you are seeking dividend income.
Legal proceedings
We are not party to nor are we aware of any material pending lawsuit, litigation or proceeding.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARJatinder S. Bhogal, Board member
- 18SEC EDGARJoseph Sierchio, Board member
- 19SEC EDGARThomas N. Gladwin, Board member
- 20SEC EDGARAlastair K. Livesey, Board member
- 21SEC EDGARRegulation FD disclosure
- 22
- 23SEC EDGARExecutive or director change
- 24
- 25SEC EDGAROther events
- 26SEC EDGARExecutive or director change
- 27SEC EDGARExecutive or director change
- 28
- 29SEC EDGAROther events
- 30
- 31
- 32SEC EDGAROther events